-
Uncategorized EU Certificate
We are proud to announce that the 78 additional medicial products (our affiliate medicial brand) have officially obtained the EU Medical Device Regulation (MDR) certification, marking another significant step in our mission to deliver safe, effective, and reliable medical products to global users. The EU MDR is one of the world’s most stringent regulatory frameworks […]
Apr 25, 2025 -
Uncategorized Avoid High Tariffs! VPLUS Water-Based Made Locally in the U.S.
Medical Atomization Technology + California-Based Manufacturing Breaks Trade Barriers and Reshapes the Industry Against the backdrop of escalating U.S.-China trade tensions, the vaping industry faces unprecedented tariff pressures. Traditional vaping brands, reliant on Chinese supply chains, have seen costs surge and market competitiveness plummet. However, VPLUS has successfully navigated this challenge through forward-thinking strategies—leveraging 100% U.S.-made, California-produced water-soluble […]
Apr 18, 2025 -
Uncategorized Competition landscape of cannabidiol market in 2025
This research project aims to sort out the product series in the field of cannabidiol, gain insight into the characteristics of the industry, the market stock space and the incremental space, and judge the position of various competitors in the field of cannabidiol in combination with the market development prospects. Cannabis is a general term […]
Apr 10, 2025 -
Uncategorized The latest Canadian research: Cannabinoids can treat COVID-19 and Long COVID , and nebulization is more effective.
A recent review by a Canadian research team suggests that cannabinoids could play a role in preventing and treating both COVID-19 and Long COVID. In a comprehensive assessment, Canadian scientists presented intriguing insights into the potential role of cannabinoids in combating SARS-CoV-2. The study, titled “Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and […]
Mar 26, 2025 -
Uncategorized VPLUS Wish you Merry Christmas
“Wishing all our valued partners, clients, and colleagues a Merry Christmas and a joyful holiday season from the VPLUS team! May the new year bring success, growth, and continued collaboration.”
Dec 18, 2024 -
Uncategorized A harmful effect of vaporized e-cigarette products in the alveolar-lining fluid and the lung
The lung’s delicate surfactant layer is of critical importance to the organ’s overall physiology and innate immune function. Both alveolar type II cells and alveolar macrophages are the principal subsets that maintain and catabolize surfactant at the liquid-air interface. Our study reveals that ENDS exposure disrupts both the lipid and protein components of pulmonary surfactant, […]
Dec 12, 2024 -
Uncategorized Effects of phytocannabinoids on Parkinson’s and Alzheimer’s disease
Neurodegenerative diseases leading to Parkinson’s disease (PD) and Alzheimer’s disease (AD) have become a major global health burden. Current treatments are mainly aimed at controlling symptoms, and there are no effective treatments in clinical practice to prevent neurodegeneration or induce neuronal repair. Therefore, the need for new research on these two diseases is urgent. The […]
Dec 05, 2024 -
Product/ Academy The therapeutic effects of cannabinoids and the way of dosing
Sativex® (nabiximols) is an oromucosal cannabinoid drug that contains 2.7 mg THC and 2.5 mg per spray. It has been approved by regulators in 29 countries for the treatment of spasticity in multiple sclerosis. The medical application of cannabis began very early. From the mid-19th century to the 20th century, it was used by the […]
Nov 26, 2024